Cancer Gene Therapy ( IF 6.4 ) Pub Date : 2023-12-11 , DOI: 10.1038/s41417-023-00707-x Yan Chen , Yu-Han Zhang , Jie Li , Lei Shi , Jia-Cheng Xie , Xue Han , Yu-Ting Chen , Meng Xiang , Bo-Wen Li , H. Rosie Xing , Jian-Yu Wang
The high mortality rate associated with melanoma primarily results from metastasis and recurrence. However, the precise mechanisms driving these processes remain poorly understood. Intercellular communication between cancer cells and non-cancer cells significantly influences the tumor microenvironment and plays a crucial role in metastasis. Therefore, our current study aims to investigate the role and mechanism of long non-coding RNAs (lncRNAs) in regulating the interaction between melanoma cancer stem cells (CSCs) and non-CSCs during the metastatic colonization process. This study has characterized a novel lncRNA called Gm33149. Importantly, we provide evidence for the first time that Gm33149, originating from highly metastatic melanoma stem cells (OL-SD), can be packaged into exosomes and transferred to low-metastatic nonstem cells (OL). Once internalized by OL cells, Gm33149 exerts its function through a competitive endogenous RNA mechanism (ceRNA) involving miR-5623-3p. Specifically, Gm33149 competitively binds to miR-5623-3p, thereby activating the Wnt signaling pathway and promoting the acquisition of a more aggressive metastatic phenotype by OL cells. In summary, our findings suggest that targeting lncRNA Gm33149 within extracellular vesicles could potentially serve as a therapeutic strategy for the treatment of metastatic melanoma.
中文翻译:
新型lncRNA Gm33149通过外泌体转移调节miR-5623-3p/Wnt轴来调节黑色素瘤的转移异质性
与黑色素瘤相关的高死亡率主要是由于转移和复发造成的。然而,驱动这些过程的精确机制仍然知之甚少。癌细胞与非癌细胞之间的细胞间通讯显着影响肿瘤微环境,并在转移中发挥至关重要的作用。因此,我们目前的研究旨在探讨长非编码RNA(lncRNA)在调节黑色素瘤癌症干细胞(CSC)和非CSC在转移定植过程中相互作用的作用和机制。这项研究鉴定了一种名为 Gm33149 的新型 lncRNA。重要的是,我们首次提供证据证明源自高转移性黑色素瘤干细胞(OL-SD)的Gm33149可以被包装到外泌体中并转移到低转移性非干细胞(OL)中。一旦被 OL 细胞内化,Gm33149 通过涉及 miR-5623-3p 的竞争性内源 RNA 机制 (ceRNA) 发挥其功能。具体来说,Gm33149 竞争性地结合 miR-5623-3p,从而激活 Wnt 信号通路并促进 OL 细胞获得更具侵袭性的转移表型。总之,我们的研究结果表明,靶向细胞外囊泡内的 lncRNA Gm33149 可能成为治疗转移性黑色素瘤的一种治疗策略。